![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.675 | 4.36 | 4.99 | - | 60,335 | 08:00:27 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.53 | 9.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
30/9/2020 17:39 | >> njb It would be good if you could join the Guild thread with your Pharma experience. I have given you some coins so that you can apply to join. Just click on the thread entitled SNG001: a potential treatment for Covid 19 and apply to join. | ![]() nobbygnome | |
30/9/2020 17:38 | njb67, As far as I can see, the Uk Government HAS put all its eggs in one basket. The vaccine basket. I am not aware that Southampton has a vaccine. Hence it does not exist within Government thinking. So far.... | ![]() wetdream | |
30/9/2020 17:27 | I think if they are not careful hospitals will have a problem soon and feel like, as normal, it is being sat on | ![]() little minx | |
30/9/2020 17:25 | LM The UK government is scanning for any treatments that can help with Covid. They have contracts in place for multiple vaccines, so are not putting all their eggs in one basket. It would make no sense to favour Oxford over Southampton. We know that Dexamethasone became standard of care in hospitalised Covid patients within six weeks of results being published, so they will move at pace too. As far as I can tell, everyone is waiting for a signal from the regulators that they are happy with the full data set. Btw, the UK is still in the EU, so the reference to EU professionals merely reflects that the scheme is available to all existing EU countries. | ![]() njb67 | |
30/9/2020 17:20 | This will stay under pressure | ![]() amaretto1 | |
30/9/2020 16:50 | Read the Clinigen/SNG release again it specifically states 'EU Professionals' so they are looking to Europe more than the UK. Obviously feel UK has tunnel vision to Oxford only | ![]() little minx |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions